Clinical and physiologic studies using diazoxide in the treatment of hypoglycemia.
D000008:Abdominal Neoplasms / Q000150:complications*; D007516:Adenoma, Islet Cell / Q000150:complications*; D000328:Adult; D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D003981:Diazoxide / Q000627:therapeutic use*; D004285:Dogs; D005260:Female; D005934:Glucagon / Q000627:therapeutic use; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007003:Hypoglycemia / Q000188:drug therapy*; D007328:Insulin / Q000097:blood; D008113:Liver Neoplasms; D008297:Male; D008654:Mesothelioma / Q000150:complications*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010179:Pancreas / Q000098:blood supply; D012039:Regional Blood Flow; D014237:Trichlormethiazide / Q000627:therapeutic use
D001786:Blood Glucose; D007328:Insulin; D005934:Glucagon; D005947:Glucose; D003981:Diazoxide; D014237:Trichlormethiazide; D006854:Hydrocortisone